Skip to main content

Digitalised measures for the prevention of central line-associated bloodstream infections: a scoping review

Abstract

Background

Central line-associated bloodstream infections (CLABSI) increase morbidity, mortality, and healthcare costs of hospitalised patients, despite being largely preventable. While evidence-based guidelines for preventing CLABSI are well-established, the implementation of these measures remain suboptimal. Digitalization presents a promising approach to improve guideline adherence, streamline implementation processes, and ultimately reduce CLABSI rates.

Methods

This scoping review aims to synthesize the available evidence on digitalised interventions for the prevention of CLABSI. A systematic search was conducted using Medline to identify studies published between January 1, 2014, and March 20, 2024, that reported on the implementation of digitalised preventive measures for CLABSI and evaluated their impact on CLABSI rates. Data extraction included study characteristics, features of the digitalised preventive measures, effectiveness in reducing CLABSI rates, and relevant process outcomes.

Results

A systematic search yielded 263 articles, of which six studies were included. Digitalised interventions were predominantly designed for use by nurses in tertiary-level hospitals (n = 6), primarily in intensive care units (n = 5) and targeted pediatric patient populations (n = 5). These measures were often implemented as part of multimodal strategies. The digital interventions included hospital dashboards (n = 2), mobile applications (n = 2), automatic notifications of catheter days (n = 1), and e-learning modules with electronic reminders (n = 1). The most common study design was quasi-experimental without an external control group. All included studies reported a reduction in CLABSI rates, ranging from 21 to 73%. Healthcare workers generally perceived these digital interventions positively.

Discussion

Digitalised interventions for CLABSI prevention seem to be effective in reducing infection rates, likely because of increasing compliance to established guidelines for CLABSI prevention.

Background

Central line-associated bloodstream infections (CLABSI) are among the most common healthcare-associated infections, posing a significant challenge for patients and healthcare systems. Patients who develop CLABSI face prolonged hospital stays and an increased risk of mortality, as compared to those who do not develop CLABSI [1, 2]. Evidence-based recommendations to prevent CLABSI prevention are well-established, however insufficiently implemented [3, 4]. The implementation of these measures is often suboptimal, likely due to the increase in the workload for healthcare teams needed to implement such measures. Several components of preventive CLABSI bundles are amenable to automation or digitalisation, such as appropriate indication for placing a central vascular catheter (CVC), checklists for insertion, reminders for the cumulative length of catheterization, and scheduled changes for CVCs, dressings and tubings. Through electronic health records and electronic prescribing systems, digital checklists and protocols can be integrated into healthcare workflows, ensuring more consistent and standardized application, ultimately improving compliance [5] and indirectly reducing CLABSI incidence. Digital tools may also facilitate the continuous education of healthcare staff by providing regular training, access to updated guidelines, and relevant resources, ensuring that Healthcare workers (HCW) have access to the latest evidence-based recommendation. In other domains, digitalization has demonstrated its potential to reduce task completion times and minimize errors [6, 7].

In this scoping review, we aimed to synthesize the available evidence on digitalised measures to prevent CLABSI, focusing on the types of interventions, challenges to their implementation, their effectiveness in reducing CLABSI rates, and HCWs’ perceptions of these approaches.

Methods

The study was designed as a scoping review and reported in accordance with the Preferred Items for Systematic Reviews and Meta-Analysis guidelines extension for Scoping Reviews (PRISMA-ScR) [8].

Eligibility criteria

A scoping review was conducted of digitalised measures to prevent CLABSI. Studies were eligible for inclusion in this review if the study reported data on the implementation process and effectiveness of a digitalised measures to prevent CLABSI. We considered a CLABSI prevention measure as ‘digitalised’ if its application involved information technology in its design or use. We considered preventive measures implemented in isolation or as part of a multimodal approach alongside other non-digital interventions. As the digitalisation of interventions is a relatively recent technological development, we limited our search to studies published between 1 January 2014 and 20 March 2024. The systematic search had no language restrictions, and there were no restrictions in study design, age categories, or setting. Studies were excluded if the digitalisation process was not sufficiently described, if the digitalised process focused only on CLABSI surveillance without any preventive measures, or if the impact on CLABSI rates was not reported.

Information sources and search

We systematically searched MEDLINE for all relevant articles meeting our eligibility criteria. The search strategy included the terms “digitalization”, “digitisation”, “automation”, “computer-assisted”, “technology”, “electronic”, “digital technology”, “digital intervention”, “digital dashboard”, “quality improvement”; “CLABSI”; “prevention”; used in various combinations. Further details of the search strategy are provided in the supplementary material (supplementary Table 1).

Selection of sources of evidence

One reviewer (BO) screened titles and abstracts to identify potentially relevant studies, and then assessed full text articles for eligibility for inclusion in the scoping review. Three reviewers (BO, NB, and GC) read and discussed the articles selected for inclusion.

Data charting process

Data from studies meeting the eligibility criteria were extracted to a table on Microsoft Word® and a data charting form was developed by identifying variables that correspond to the aims of the review. We extracted data on study characteristics (year of the study, study design, setting, study population), on the features of the digitalised preventive measures (type of intervention, non-digitalised measures that were implemented concurrently) and on the impact on CLABSI rates. We also collected data on process outcomes related to the implementation of digitalised preventive measures and on levels of satisfaction of healthcare professionals on the digitalisation of preventive measures, where available. For each study, the reduction in the rate in CLABSI incidence was calculated as the difference between the CLABSI incidence rates before (corresponding to an average over a baseline period) and after the digitalised preventive measure(s) were introduced.

The quality of the studies was evaluated using the Newcastle-Ottawa quality assessment scale [9], which was applied to cohort studies on the following three criteria: selection of the study population, comparability of the groups on the basis of the design or analysis and study outcomes.

Results

Selection of sources of evidence

Our systematic search retrieved 263 records, of which 44 studies were assessed for full-text eligibility. After excluding 36 studies that described non-digitalised interventions, one study in which the digitisation process was unclear and one further study that did not assess the impact on CLABSI rates, six studies were included in this review [10,11,12,13,14,15](Fig. 1).

Fig. 1
figure 1

Study flow diagram

Characteristics of studies

The characteristics of the six included studies are presented in Table 1. All had a quasi-experimental design, with only one having an external control group [10], and no randomized-controlled study was included. The studies were most frequently performed in tertiary care hospitals (n = 5), with only one study also involving two community hospitals. The target population in each of the studies were HCWs, primarily nurses for 2 studies. The studies were conducted in ICU (n = 5) and non-ICU wards (n = 4), and most studies were conducted in paediatrics (n = 4).

Table 1 Study characteristics

Digitalised measures for prevention of CLABSI

The overall aim of digitalised preventive measures in each of the included studies was to reduce CLABSI rate by improving the compliance to pre-established protocols for prevention. Two studies (Papeger et al.. and Chemparathy et al..) carried out in 2014 and 2021, respectively, focused on the implementation of a hospital dashboard [11, 13]. In one study [11], the aim was to produce a digital interface specific to each patient with a CVC, which would enable HCWs to view data related to the insertion and maintenance of the CVC. In the other study [13], the dashboard was part of a hospital-wide automated system, and monitored observance with bundle for CLABSI prevention.

Two studies investigated the use of a mobile application to prevent CLABSI. The CLABSI app® (Chatter, Salesforce Inc., San Francisco, California) [10], enabled HCWs in the intervention group to self-assess their knowledge and practice of CLABSI prevention measures using real-time microlearning. It also included an option enabling members of the intervention group to assess themselves against other group members from other teams and units at regular intervals. The second application, called Rounds+® (GetWellNetwork, Inc., Bethesda, Md.) [14], enabled trained staff members, known as ‘influencers’, to observe and document the application of CVC maintenance measures by other nurses during rounds, while improving inappropriate procedures by direct feed-back in real time. The study by Bae et al., looked at the impact of automatic notification of the number of CVC-days after insertion on the incidence of CLABSI [15]. Finally, Engel et al. studied the benefits of the evidence-based practice of using 2% chlorhexidine gluconate (CHG) cloths for daily bathing in a multifaceted CLABSI prevention strategy which included an e-learning module on CHG bathing coupled with electronic reminders in the EHR for the daily CHG bathing [12].

Impact on CLABSI rates

In each of the studies, the impact of the intervention on the CLABSI rate was assessed either by comparing pre- and post-intervention rates [6,7,8, 10, 11] or using the standardized infection ratio, defined as the ratio of the actual CLABSI rate to the expected rate [14]. Each of the studies demonstrated a substantial reduction effect on CLABSI rates, ranging from 21 to 73% following the implementation of digitalised prevention measures (Table 2). The CLABSI rate reduction was considered statistically significant in 3 studies [10, 11, 15] and not statistically significant in one study [12]. In 2 studies, a statistical comparison between the two periods was either not performed [14] or not described in the methods [13].

Table 2 Impact on CLABSI rates, process outcomes and user satisfaction with the digitalised intervention

Process outcomes related to the implementation of digitalised preventive measures

Three studies described the digitalisation of preventive measures as having increased the compliance of HCWs to the preventive measures [12,13,14], while in one study compliance with core preventive measures (all already ≥ 98.8% in the preceding year), decreased marginally during the intervention period on 3 bundle elements. Additionally, the overall compliance rates during the intervention period were slightly lower in the intervention group (94%) than the control group (98%) [10].

Perception and satisfaction

Three studies collected data on perception of the digitalised preventive measures by HCWs [12,13,14]. Hugo et al. [14] noted initial reluctance, as demonstrated by a drop in the compliance to the maintenance CVC bundle (86.9–40%), followed by an increase in compliance from 40 to 87.1% after some adjustments. In the study conducted by Engel et al. [12], 85% of the nurses reported being satisfied with the e-learning support on CHG bathing, and 62% reported being satisfied with the electronic alert in the EHR for the daily CHG bathing in the worklist task. Chemparathy et al. [13] noted reluctance of some specific units (NICU, Hematology/Oncology, and stem cell transplant units) to the adoption of the use of a dashboard. These units had previously established processes for bundle rounds and trust them to be more accurate, resulting in a hesitancy to utilize the dashboard. For instance, the NICU used real time coaching on bedside rounding for all patients with CVC and preferred this to the automated process.

Quality of the studies

According to the Newcastle-Ottawa quality assessment scale, the studies included in this review were assessed as being of good (n = 1) [12], fair (n = 4) [10, 13,14,15], or poor quality (n = 1) [11]. All studies clearly defined objectives and outcomes. The minimum duration of the interventions was one year, with appropriate follow-up, providing sufficient time to evaluate the impact on CLABSI rates. However, several limitations were identified. The lack of randomization in the one study with a defined intervention and control group [8] introduced potential bias. Most studies relied on historical cohorts, which inherently carry a risk of selection bias. In several studies, multimodal interventions introduced in parallel digitalised and non-digitalised components; thus, it was not possible to distinguish which components of the multimodal intervention were most effective. Additionally, in five out of six studies, it was unclear whether prior preventive interventions had already influenced CLABSI rates in ways that were not accounted for. Moreover, most studies were conducted in single-center settings, limiting the generalizability of findings. Process outcomes were not systematically measured, further restricting the ability to draw robust conclusions about the mechanisms underlying the reported reductions in CLABSI rates. A detailed table of the quality assessment criteria is provided in the supplementary material (supplementary Table 2).

Discussion

This scoping review summarized the available evidence on the use of digitalised measures to prevent CLABSI and their impact on CLABSI rates. Digitalised interventions for the prevention of CLABSI appear to be effective in improving compliance with preventive measures and reducing CLABSI rates. The limited number of studies conducted in this field suggests that the digitalisation of preventive measures for CLABSI remains relatively novel.

The digitalisation of preventive measures presents an opportunity to facilitate implementation and increase compliance to recommended preventive measures, ultimately reducing CLABSI incidence. Several types of digitalised measures were proposed across these studies. First, electronic reminders integrated into the EHR (list of indications, insertion checklist, dressing change reminders, number of catheter days, alert to reassess the need for catheter retention) could improve compliance with preventive measures for CVC insertion and care. By integrating them into the EHR or an application, compliance with these measures can be monitored in an automated way, allowing timely feedback with comparisons across teams or units. Second, digitalisation offers the opportunity for e-learning and micro-learning with small video capsules that can be visualised during care to improve HCWs’ knowledge of good clinical practices for CVC insertion, CVC care or identification of signs of CVC infection. Third, digitalisation offers the opportunity to improve coordination between HCWs. In this context, dashboards can be used to summarise patient-specific data and support decision making by focusing on the elements of the bundle that may have been performed incorrectly, providing a visualisation of the need for corrective action, monitoring and evaluation [16]. Finally, dashboards could also provide visual comparison of HCW performance at the team or unit levels, creating emulation between teams. The different types of digitalised intervention are summarised in Table 3.

Table 3 Digitalised interventions for CLABSI prevention

Process indicators were collected in all the studies included in this review, and most showed an increase in the completion of activities within the CLABSI prevention bundle. However, slow progress was observed in some studies and even worse performance at the beginning of one study. To better understand how digitalisation may impact CLABSI rates, studies should also collect data on specific process indicators, such as acceptability, uptake, and sustainability of the intervention. Across the included studies, satisfaction levels varied: some features, such as e-learning, were highly rated, whereas others, like checklists, received more moderate feedback. Studies that evaluated acceptance highlight the necessity of an adaptation period for successful adoption [13, 14]. While digital tools offer significant potential, their implementation is not without challenges. In one study, units with higher workloads, typically associated with the care of vulnerable patients (neonatology and intensive care), tended to prefer existing algorithms and procedures and perceived digitalisation as a constraint, rather than an opportunity [10]. Implementation is facilitated by involving end-users early in the design of the intervention and by conducting usability testing throughout the development [17]. A detailed and comprehensive description of the intervention was not always provided in the included studies. An implementation framework to design the intervention properly and adequate description of the interventions are necessary to allow replication. Finally, although technical solutions are essential for implementation; they are rarely sufficient on their own to drive meaningful change. Successful adoption requires adapting these processes to the social and organizational context [18].

Regarding conclusions on the effect on CLABSI rates, the included studies were limited to non-randomized designs, often lacking a control group, for which we cannot rule out time-related confounding. In some studies, the reporting of comparison methods was clearly inadequate. Positive findings in this context should be interpreted cautiously. A high risk of bias is associated with greater intervention effect, making a real assessment of the impact of the intervention alone difficult [19]. Stronger study design to properly assess the impact of an infection prevention intervention includes cluster-randomized trials and quasi-experimental studies, ideally with an external control group, using interrupted time-series analysis [20].

This scoping review has several limitations. Firstly, we performed a systematic search of a single database of peer-reviewed literature. Further, digitalisation of preventive measures for CLABSI is a relatively recent concept and we used a relatively conservative definition to consider preventive measures as being ‘digitalised’. We considered only studies published during the last 10 years, although this may have missed relevant and pioneering studies published prior to 2014. Finally, the digitalisation process was frequently part of a larger implemented bundle with non-digitalised components, so the observed impact on the CLABSI rates may reflect the effectiveness of other bundle components, rather than digitalisation itself.

Conclusion

Digitalised interventions for the prevention of CLABSI appear to be effective in improving compliance with preventive measures and reducing CLABSI rates. However, very few studies have been published and most of them suffer from weak design (quasi-experimental design without control group). Future research should focus on a rigorous evaluation of the performance and effectiveness of digital CLABSI prevention measures, ideally with interventions integrated into electronic medical records and using appropriate design and include an evaluation of costs.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infect Févr. 2015;43(1):29–36.

    Article  Google Scholar 

  2. Yu KC, Jung M, Ai C. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Infect Control Hosp Epidemiol Déc. 2023;44(12):1920–6.

    Article  Google Scholar 

  3. Buetti N, Marschall J, Drees M, Fakih M, Hadaway L, Maragakis L, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 19 Avr. 2022;43:1–17.

    Google Scholar 

  4. O’Grady NP. Prevention of central Line-Associated bloodstream infections. N Engl J Med 21 Sept. 2023;389(12):1121–31.

    Article  Google Scholar 

  5. Bosk CL, Dixon-Woods M, Goeschel CA, Pronovost PJ. Reality check for checklists. Lancet Lond Engl 8 Août. 2009;374(9688):444–5.

    Article  Google Scholar 

  6. Huang WL, Liao SL, Huang HL, Su YX, Jerng JS, Lu CY, et al. A case study of lean digital transformation through robotic process automation in healthcare. Sci Rep 25 Juin. 2024;14(1):14626.

    Article  CAS  Google Scholar 

  7. Kaihlanen AM, Laukka E, Nadav J, Närvänen J, Saukkonen P, Koivisto J et al. The effects of digitalisation on health and social care work: a qualitative descriptive study of the perceptions of professionals and managers. BMC Health Serv Res. 30 juin. 2023;23(1):714.

  8. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. oct 2018;2(7):467–73.

  9. Ottawa Hospital Research Institute [Internet]. [cité 31 janv 2025]. Disponible sur: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

  10. Orwoll B, Diane S, Henry D, Tsang L, Chu K, Meer C, et al. Gamification and microlearning for engagement with quality improvement (GAMEQI): A bundled digital intervention for the prevention of central Line-Associated bloodstream infection. Am J Med Qual Off J Am Coll Med Qual. 2018;33(1):21–9.

    Article  Google Scholar 

  11. Pageler NM, Longhurst CA, Wood M, Cornfield DN, Suermondt J, Sharek PJ, et al. Use of electronic medical record-enhanced checklist and electronic dashboard to decrease clabsis. Pediatr Mars. 2014;133(3):e738–746.

    Article  Google Scholar 

  12. Engel J, Meyer BM, McNeil GA, Hicks T, Bhandari K, Hatch D, et al. A quality improvement project to decrease clabsis in Non-ICU settings. Qual Manag Health Care 1 Sept. 2023;32(3):189–96.

    Article  Google Scholar 

  13. Chemparathy A, Seneviratne MG, Ward A, Mirchandani S, Li R, Mathew R, et al. Development and implementation of a Real-time Bundle-adherence dashboard for central Line-associated bloodstream infections. Pediatr Qual Saf. 2021;6(4):e431.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hugo MC, Rzucidlo RR, Weisert LM, Parakati I, Schroeder SK. A quality improvement initiative to increase central line maintenance bundle compliance through Nursing-led rounds. Pediatr Qual Saf Févr. 2022;7(1):e515.

    Article  Google Scholar 

  15. Bae S, Kim Y, Chang HH, Kim S, Kim HJ, Jeon H, et al. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study. BMC Infect Dis 8 Juill. 2022;22(1):604.

    Article  Google Scholar 

  16. Beville ASM, Heipel D, Vanhoozer G, Bailey P. Reducing central line associated bloodstream infections (CLABSIs) by reducing central line days. Curr Infect Dis Rep 2 Nov. 2021;23(12):23.

    Article  Google Scholar 

  17. Anderson J, Gosbee LL, Bessesen M, Williams L. Using human factors engineering to improve the effectiveness of infection prevention and control. Crit Care Med Août. 2010;38(8 Suppl):S269–281.

    Article  Google Scholar 

  18. Waltz TJ, Powell BJ, Fernández ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 29 avr. 2019;14(1):42.

  19. Alsaggaf R, O’Hara LM, Stafford KA, Leekha S, Harris AD, Program CPE. Quasi-experimental studies in the fields of infection control and antibiotic resistance, ten years later: A systematic review. Infect Control Hosp Epidemiol Févr. 2018;39(2):170.

    Article  Google Scholar 

  20. de Kraker MEA, Abbas M, Huttner B, Harbarth S. Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis Nov. 2017;23(11):819–25.

    Google Scholar 

Download references

Funding

Open access funding provided by University of Geneva

Author information

Authors and Affiliations

Authors

Contributions

G.C and N.B designed the study. B.O performed the search and extracted the data. B.O, G.C and N.B discussed the results. B.O. and G.C. drafted the main text and tables of the manuscript. B.O. prepared Figure 1. R.G. and S.H. revised the manuscript and made substantial revisions. All authors revised the manuscript.

Corresponding author

Correspondence to Gaud Catho.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

13756_2025_1549_MOESM1_ESM.docx

Supplementary Material 1: Supp. Table 1: Mesh terms for Search strategy. Supp. Table 2: Quality assessment of the studies.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obama, B.M., Grant, R., Harbarth, S. et al. Digitalised measures for the prevention of central line-associated bloodstream infections: a scoping review. Antimicrob Resist Infect Control 14, 45 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13756-025-01549-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13756-025-01549-y

Keywords